All You Need to Know on the Ecuador Sessions 2020

After 3 years, SOLACI returns to Ecuador -this time to the beautiful city of Manta- to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region.

Jornadas Ecuador 2020

Below you will find all the relevant information you need to know about the Ecuador Regional Sessions 2020.

When?

March 6th & 7th, 2020.

Where?

They will take place in Manta, Ecuador. (Oro Verde Hotel).

How can I register?

By entering HERE.

Which are the registrations fees?

  • Specialists | USD 160.
  • Generales Physicians | USD 130.
  • Students | USD 100.
  • Technicians & Nurses | USD 80.

Scientific Program

Access the scientific program

Which are the relevant topics?

  • Acute Coronary Syndrome
  • Coronary interventionism.
  • Aortic Valve Interventions.
  • Mitral valve.
  • Antithrombotic Therapy
  • Atrial Fibrillation Intervention.
  • Pediatric intervention.
  • Live cases.
  • Clinical Case Contest for Young Interventionists
  • Imagen Contest.

Who are organizing these sessions?

The Latin American Society of Interventional Cardiology alongside with the Ecuadorian Society of Cardiovascular Interventions (SEICAV).

Contact

¿En qué consiste el Concurso de Imágenes?

It is an interactive activity consisting in the presentation of a case series based on imaging. One or more multiple-choice questions will be asked regarding these cases. Participants will send their answers through their smartphones, which will connect to the evaluation information system. The Contest will also include a few questions on general knowledge for entertainment purposes. The participant with more correct answers will be the winner. Its first price will be the fee for full registration, lodging and transportation costs to Chile Sessions 2016 (November 30th and December 1st).

What are the winners of the Imaging and Clinical Case Contests awarded?

All costs to some of the next SOLACI Sessions will be waived.

SOLACI Board

Jornadas SOLACI Director
Dr. Mario Araya (Chile).

Jornadas SOLACI Vice Director
Dr. Gustavo Vignolo (Uruguay).

SOLACI Sessions Scientific Committee Director
Dr. Marcio Montenegro (Brasil).

SEICAV Board

SEICAV President
Dr. Gustavo Hidalgo.

SEICAV Vice President
Dr. José Vivas Guijarro.

SEICAV Secretary
Dr. Alfonso Zambrano.

 SEICAV Pro-secretary
Dr. Wishton Moreira.

SEICAV Vocal
Dr. Ricardo Ortíz.

SEICAV Vocal
Dr. Erwin Téllez.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....